Identification of residual disease followed by trade-off analysis between drug optimisation, MRD and sustenance of normal haematopoiesis under maintenance chemotherapy in childhood ALL.
Identification of residual disease followed by trade-off analysis between drug optimisation, MRD and sustenance of normal haematopoiesis under maintenance chemotherapy in childhood ALL.
(xsd:string)
Identification of residual disease followed by trade-off analysis between drug optimisation, MRD and sustenance of normal haematopoiesis under maintenance chemotherapy in childhood ALL.
(xsd:string)